ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
58 hedge funds and large institutions have $57.1M invested in Zynerba Pharmaceuticals, Inc in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Holders
58
Holding in Top 10
–
Calls
$2.37M
Puts
$1.03M
Top Buyers
| 1 | +$1.51M | |
| 2 | +$1.41M | |
| 3 | +$580K | |
| 4 |
Two Sigma Investments
New York
|
+$530K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$416K |
Top Sellers
| 1 | -$3.3M | |
| 2 | -$1.45M | |
| 3 | -$1.3M | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$1.21M |
| 5 |
PP
PDT Partners
New York
|
-$804K |